PRESS RELEASE published on 06/19/2026 at 12:31, 1 month 22 days ago Communiqué de presse : Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple Sanofi obtient l'approbation japonaise pour Sarclisa SC, traitement sous-cutané du myélome multiple, offrant commodité et efficacité. Possibilité d'administration via injecteur portable Japon Sanofi Myélome Multiple Approbation Sarclisa
PRESS RELEASE published on 06/19/2026 at 12:31, 1 month 22 days ago Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Sanofi's Sarclisa subcutaneous formulation approved in Japan for multiple myeloma patients, offering a convenient treatment option via OBI administration and manual injection Japan Sanofi Multiple Myeloma Sarclisa Subcutaneous Formulation
BRIEF published on 06/19/2026 at 10:05, 1 month 22 days ago Sanofi et HEC Paris lancent des bourses pour les futurs leaders de la santé Management Sanofi Bourses Leaders Santé HEC Paris
BRIEF published on 06/19/2026 at 10:05, 1 month 22 days ago Sanofi and HEC Paris launch scholarships for future healthcare leaders Scholarships Management Sanofi HEC Paris Health Leaders
PRESS RELEASE published on 06/19/2026 at 10:00, 1 month 22 days ago Communiqué de presse : Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé Sanofi et HEC Paris lancent la 'Sanofi MBA Life Sciences Scholarship' pour soutenir les futurs leaders de la santé. Programme de bourses pour le MBA HEC Paris Santé Sanofi Bourses Leaders HEC Paris
BRIEF published on 06/13/2026 at 00:14, 1 month 29 days ago Le Tzield de Sanofi obtient l'approbation de la FDA pour le traitement du diabète de type 1 Sanofi Diabète De Type 1 Approbation Tzield Approbation Accélérée De La FDA Étude PROTECT
BRIEF published on 06/13/2026 at 00:14, 1 month 29 days ago Sanofi's Tzield Gains FDA Approval for Type 1 Diabetes Therapy Sanofi FDA Accelerated Approval Type 1 Diabetes Tzield Approval PROTECT Study
PRESS RELEASE published on 06/13/2026 at 00:09, 1 month 29 days ago Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes Sanofi's Tzield receives US FDA approval as first disease-modifying therapy for stage 3 type 1 diabetes, targeting autoimmune attack against insulin-producing beta cells FDA Approval Sanofi Type 1 Diabetes Tzield Autoimmune Therapy
BRIEF published on 06/04/2026 at 10:12, 2 months 7 days ago Sanofi lance son plan mondial d'achat d'actions pour les employés à l'horizon 2026. Actionnariat Plan D'achat D'actions Sanofi Actions Des Employés Initiative Mondiale
BRIEF published on 06/04/2026 at 10:12, 2 months 7 days ago Sanofi Introduces 2026 Global Employee Stock Purchase Plan Shareholding Stock Purchase Plan Sanofi Employee Shares Global Initiative
Published on 08/12/2026 at 00:00, 6 hours 33 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 6 hours 53 minutes ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/11/2026 at 23:15, 7 hours 18 minutes ago Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador
Published on 08/11/2026 at 23:00, 7 hours 33 minutes ago Prospectiva Resources Ltd. Completes Qualifying Transaction
Published on 08/11/2026 at 22:55, 7 hours 38 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 08/12/2026 at 00:18, 6 hours 15 minutes ago EQS-Adhoc: Hawesko Holding SE updates forecast for the 2026 financial year
Published on 08/11/2026 at 22:10, 8 hours 23 minutes ago Quantinuum Reports Second Quarter 2026 Results
Published on 08/11/2026 at 22:05, 8 hours 28 minutes ago Quantinuum and Oracle Partner to Accelerate Hybrid Quantum Compute Adoption on Oracle Cloud Infrastructure
Published on 08/11/2026 at 18:59, 11 hours 34 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: SOEC realignment leads to adjustment of FY 2025/26 EBIT guidance; Order intake and sales outlook updated based on current business performance
Published on 08/11/2026 at 18:02, 12 hours 31 minutes ago TerraMaster lance officiellement son programme de mise à niveau du stockage : boostez votre capacité de stockage pour entrer dans l’ère de l’IA
Published on 08/11/2026 at 17:45, 12 hours 48 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 12 hours 53 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 1 day 12 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 1 day 12 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026